Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexavar and Tarceva in Advanced NSCLC
NCT00600015Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Feb 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in non-small cell lung cancer (NSCLC), sponsored by SCRI Development Innovations. Started Feb 2008; status: completed.
02
Drugs
sorafenib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00600015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00600015.